Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Fujihashi
Gaku Fujihashi, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20110030781 | PASTE FOR DYE-SENSITIZED SOLAR CELL, TRANSPARENT INSULATION FILM FOR DYE-SENSITIZED SOLAR CELL, DYE-SENSITIZED SOLAR CELL, AND DYE-SENSITIZED SOLAR CELL FABRICATION METHOD - A paste containing a silica polymer, made by substituting at least some of the surface functional groups thereof with alkyl groups, and solvent-removable inorganic particles is prepared, and the paste is applied and fired to form a transparent insulating film in a dye-sensitized solar cell. | 02-10-2011 |
Hisayuki Fujihashi, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20080243012 | Method of compressing electrocardiogram data and electrocardiogram telemetry system using the same - In an electrocardiogram telemeter, a data acquirer is operable to acquire electrocardiogram data. A data compressor is operable to compress the electrocardiogram data with either a wavelet transform, a Huffman coding, or an arithmetic coding, thereby generating compressed electrocardiogram data adapted to be transmitted to a remote receiver which is configured to reconstruct the electrocardiogram data. | 10-02-2008 |
Kohtaro Fujihashi, Hoover, AL US
| Patent application number | Description | Published |
|---|---|---|
| 20090169578 | TOLERIZING AGENTS - Described herein is the development of fusion proteins useful for inducing tolerance in a subject. In particular embodiments, the tolerizing agents are useful for influence autoimmune, inflammatory, and/or allergic reactions. Example tolerizing fusion proteins contain a targeting portion (which delivers the fusion protein) and a toleragen or allergen or other antigen to which tolerance is desired in a subject. In particular examples, it is demonstrated that a pσ1 fusion protein, when administered orally, facilitates systemic and mucosal tolerance. Also described is the nasal delivery of fusion proteins, for instance for restoring immunogenicity. | 07-02-2009 |
| 20110135678 | TOLERIZING AGENTS - Described herein is the development of fusion proteins useful for inducing tolerance in a subject. In particular embodiments, the tolerizing agents are useful for influence autoimmune, inflammatory, and/or allergic reactions. Example tolerizing fusion proteins contain a targeting portion (which delivers the fusion protein) and a toleragen or allergen or other antigen to which tolerance is desired in a subject. In particular examples, it is demonstrated that a pσ1 fusion protein, when administered orally, facilitates systemic and mucosal tolerance. Also described is the nasal delivery of fusion proteins, for instance for restoring immunogenicity. | 06-09-2011 |
Masahiro Fujihashi, Kyoto JP
| Patent application number | Description | Published |
|---|---|---|
| 20090221524 | ODCASE INHIBITORS FOR THE TREATMENT OF MALARIA - The present invention includes methods of treating or preventing malaria by administering an anti-malarial effective amount of 6-substituted uridine derivatives to a subject need thereof. The invention also includes new 6-substituted uridine derivatives for use as therapeutics, in particular to treat malaria. | 09-03-2009 |